Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × Cholecalciferol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Vitamin D Deficiency 19 Prostatic Neoplasms 14 Polycystic Ovary Syndrome 10 Neoplasms 8 Colonic Neoplasms 8 Rectal Neoplasms 6 Osteoporosis 5 Myelodysplastic Syndromes 5 Colorectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Insulin Resistance 2

Interventions

pembrolizumab 2 nintedanib 1 dabrafenib 1 Vitamin D 1 Surveys and Questionnaires 1 Paclitaxel 1 Eye Movement Desensitization Reprocessing 1 Electrochemotherapy 1 Cholecalciferol 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed

436 enrolled 16 charts

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡